Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Buy
181,264
+118,618
+189% +$6.14M 0.05% 324
2026
Q1
$3.18M Buy
62,646
+35,887
+134% +$1.67M 0.01% 585
2025
Q4
$789K Buy
+26,759
New +$727K ﹤0.01% 745
2025
Q1
Sell
-215,724
Closed -$8.97M 1240
2024
Q4
$8.97M Buy
+215,724
New +$10.3M 0.27% 83

Other funds holding MRNA

Jain Global's MRNA Position: Q2 2026 in Review

Jain Global increased its Moderna (MRNA) stake by 189% in Q2 2026, buying an estimated $6.14M and bringing the position to 181,264 shares worth $12.7M. The position accounts for 0.05% of the portfolio, ranked #324.

Jain Global first reported a position in MRNA in Q4 2024 and has held it in 4 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Jain Global held 181,264 shares of Moderna worth $12.7M as of Q2 2026.
  • Jain Global bought 118,618 Moderna shares in Q2 2026, an estimated $6.14M.
  • Moderna made up 0.05% of Jain Global's portfolio in Q2 2026, its #324 holding.
  • Jain Global first reported a position in Moderna in Q4 2024 and has held it in 4 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.